Australia's expanding landscape of peptide research and manufacturing is witnessing significant advancement, driven by both academic institutions and a selection of specialized companies. Significant research efforts are now focused on creating novel therapeutic polypeptides for a spectrum of applications, including oncology, circulatory diseases,